Aspirin-triggered 15-epi-lipoxin A4 signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation
Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells
M.H. Petri, C. Tellier, C. Michiels, I. Ellertsen, J.M. Dogne, and M. Bäck Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells Biochem. Biophys. Res. Commun. 441 2013 393 398
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis
K.J. Ho, M. Spite, C.D. Owens, H. Lancero, A.H. Kroemer, and R. Pande Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis Am. J. Pathol. 177 2010 2116 2123
The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
M. Petri, A. Laguna-Fernandez, M. Gonzalez-Diez, G. Paulsson-Berne, G. Hansson, and M. Bäck The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability Cardiovasc. Res. 2014 10.1093/cvr/cvu224
Anti-inflammatory role of the murine formyl-peptide receptor 2: Ligand-specific effects on leukocyte responses and experimental inflammation
N. Dufton, R. Hannon, V. Brancaleone, J. Dalli, H.B. Patel, and M. Gray Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation J. Immunol. 184 2010 2611 2619
Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis
H. Hlawaty, M.P. Jacob, L. Louedec, D. Letourneur, C. Brink, and J.B. Michel Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis Arterioscler. Thromb. Vasc. Biol. 29 2009 518 524
D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury
T. Miyahara, S. Runge, A. Chatterjee, M. Chen, G. Mottola, and J.M. Fitzgerald D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury FASEB J. 27 2013 2220 2232
Neutrophil-derived cathelicidin protects from neointimal hyperplasia
O. Soehnlein, S. Wantha, S. Simsekyilmaz, Y. Doring, R.T. Megens, and S.F. Mause Neutrophil-derived cathelicidin protects from neointimal hyperplasia Sci. Transl. Med. 3 2011 103ra98